参考文献/References:
［1］ PARKINSON J.Mr.Parkinson′s letter on the committee of apothecaries［J］.Med Phys J,1813,29(168):132-133.
［2］ CHEN Z,LI G,LIU J.Autonomic dysfunction in Parkinson′s disease:implications for pathophysiology,diagnosis,and treatment［J］.Neurobiol Dis,2019,134:104700.
［3］ FU P,GAO M,YUUNG K K L.Association of intestinal disorders with Parkinson′s disease and Alzheimer′s disease:a systematic review and meta-analysis［J］.ACS Chemical Neuroence,2020,11(3):395-405.
［4］ JELLINGER K A.Non-motor symptoms of Parkinson′s disease［J］.Eur J Neurol,2009,16(9):e168.
［5］ DE RIJK M C,BRETELER M M,GRAVELAND G A,et al.Prevalence of Parkinson′s disease in the elderly the rotterdam study［J］.Neurology,1995,45(12):2143-2146.
［6］ CHEKANI F,BALI V,APARASU R R.Quality of life of patients with Parkinson′s disease and neurodegenerative dementia:a natio-nally representative study［J］.Res Social Adm Pharm,2016,12(4):604-613.
［7］ 傅文玉,黄岩.黑质、纹状体与帕金森病［J］.解剖科学进展,1997,3(1):51-56.
［8］ MINGAZOV E R,PAVLOVA E N,SURKOV S A,et al.Proteins of the vesicular cycle as a marker of neuroplasticity of dopaminergic neurons in the substantia nigra of the brain［J］.Dokl Biochem Biophys,2019,489(1):399-402.
［9］ MARTIN-BARTIN A,LAO-KAIM N P,ROUSSAKIS A A,et al.Relationship between neuromelanin and dopamine terminals within the Parkinson′s nigrostriatal system［J］.Brain,2019,142(7):2023-2036.
［10］ BARBOSA E N B E,CHARCHAT-FICHMAN H.Systematic review of neuropsychological instruments used in subthalamic nucleus deep brain stimulation in Parkinson′s disease patients［J］.Dement Neuropsychol,2019,13(2):162-171.
［11］ TOURN N A,SENEL G B,GUNDUZ A,et al.Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson′s disease［J］.Rev Neurol,2020,176(4):277-284.
［12］ PAN P Y,YUE Z.Genetic causes of Parkinson′s disease and their links to autophagy regulation［J］.Parkinsonism Relat Disord,2014,20（Suppl 1）:S154-S157.
［13］ ZUO L,MOTHERWELL M S.The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson′s disease［J］.Gene,2013,532(1):18-23.
［14］ KOZAKIEWICZ M,ROWINSKI R,KORNATOWSKI M,et al.Relation of moderate physical activity to blood markers of oxidative stress and antioxidant defense in the elderly［J］.Oxid Medi Cell Longev,2019,2019:5123628.
［15］ 杨梅桂,郑凯,宋质银.线粒体-内质网相互作用机制、功能及其与相关疾病的关系研究进展［J］.新乡医学院学报,2020,37(10):996-1001.
［16］ SIRISHA A,GAUR G S,PAL P,et al.Effect of honey and insulin treatment on oxidative stress and nerve conduction in an experimental model of diabetic neuropathy Wistar rats［J］.PLoS One,2021,16(1):e0245395.
［17］ ALESSI D R,SAMMLER E.LRRK2 kinase in Parkinson′s disease［J］.Science,2018,360(6384):36-37.
［18］ CRISTINA T P,PABLO M,TERESA P M,et al.A genetic analysis of a Spanish population with early onset Parkinson′s disease［J］.PLoS One,2020,15(9):e0238098.
［19］ 汪锡金,张煜,陈生弟.帕金森病发病机制与治疗研究十年进展［J］.中国现代神经疾病杂志,2010,10(1):36-42.
［20］ KASTEN M,HARTMANN C,HAMPF J,et al.Genotype-phenotype relations for the Parkinson′s disease genes parkin,PINK1,DJ1:MDSGene systematic review［J］.Mov Disord,2018,33(5):730-741.
［21］ KOTAGAL V,BOHNEN I,MARTIJN L T M,et al.Cerebral amyloid burden and hoehn and yahr stage 3 scoring in Parkinson disease［J］.J Parkinsons Dis,2017,7(1):143-147.
［22］ ZHANG J Y,WANG G.Genetic predisposition to bullous pemphigoid［J］.J Dermatol,2020,100(2):86-91.
［23］ KAIYRZHANOV R,RIZIG M,AITKULOVA A,et al.Parkinson′s Disease in Central Asian and Transcaucasian Countries:a review of epidemiology,genetics,clinical characteristics,and access to care［J］.J Parkinsons Dis,2019,2019:2905739.
［24］ CHANG C C,LIN T M,CHANG Y S,et al.Autoimmune rheumatic diseases and the risk of Parkinson disease:a nationwide population-based cohort study in Taiwan［J］.Ann Med,2018,50（1）:83-90.
［25］ LANGSTON J W.The MPTP story［J］.J Parkinson′s Dis,2017,7(Suppl 1):S11-S22.
［26］ CHO H,KANG K.Effects of environmental enrichment on neurotrophins in an MPTP-induced Parkinson′s disease animal model:a randomized trial［J］.Biol Res Nurs,2020,22(4):506-513.
［27］ ZHI Y,JIN Y,PAN L,et al.Schisandrin a ameliorates MPTP-induced Parkinson′s disease in a mouse model via regulation of brain autophagy［J］.Arch Pharm Res,2019,42(11):1012-1020.
［28］ LI X,ZHANG J,RONG H,et al.Ferulic acid ameliorates MPP+/MPTP-induced oxidative stress via ERK1/2-dependent Nrf2 activation:translational implications for Parkinson disease treatment［J］.Mol Neurobiol,2020,57(7):2981-2995.
［29］ KAYA D.Optimization of SVM parameters with hybrid CS-PSO algorithms for Parkinson′s disease in LabVIEW environment［J］.Parkinsons Dis,2019,2019(18):1-9.
［30］ 刘丽,罗广轩,林健琳,等.虫草素对MPTP诱导的帕金森病小鼠运动与认知能力的影响［J］.中国病理生理杂志,2019,35(2):326-331.
［31］ BROOKS J,EVERETT J,LERMYTE F,et al.Analysis of neuronal iron deposits in Parkinson′s disease brain tissue by synchrotron X-ray spectromicroscopy［J］.J Trace Elem Med Biol,2020,62:126555.
［32］ 杨仕林.生活方式,环境因素与帕金森病发病风险的病例对照研究［D］.北京：协和医学院,2012.
［33］ MRQUEZ I,MU N~OZ M F,AYALA A,et al.Effects on goal directed behavior and habit in two animal models of Parkinson′s disease［J］.Neurobiol Learn Memory,2020,169:107190.
［34］ NASUTION R A,ISLAM A A,HATTA M,et al.Role of CAPE in reducing oxidative stress in animal models with brain injury［J］.Ann Med Surg,2020,57:118-122.
［35］ VERMAV A,RAVINDRANATH V.CaV1.3 L-type calcium channels increase the vulnerability of substantia nigra dopaminergic neurons in MPTP mouse model of Parkinson′s disease［J］.Front Aging Neurosci,2020,11:382.
［36］ WU J R,TUO Q Z,LEI P.Ferroptosis,a recent defined form of critical cell death in neurological disorders［J］.J Mol Neurosci,2018,66(2):197-206.
［37］ GUINEY S J,ADLARD P A,BUSH A I,et al.Ferroptosis and cell death mechanisms in Parkinson′s disease［J］.Neurochem Int,2017,104:34-48.
［38］ PARK J S,PARK J H,Kim K Y.Neuroprotective effects of myristargenol:a against glutamate-induced apoptotic HT22 cell death［J］.Royal Soc Chemistry,2019,9(54):31247-31254.
［39］ SLITER D A,MARTINEZ J,HAO L,et al.Parkin and PINK1 mitigate STING-induced inflammation［J］.Nature,2018,561(7722):258-262.
［40］ OSTER S,RADAD K,SCHELLER D,et al.Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture［J］.Eur J Pharmacol,2014,724:31-42.
［41］ NALLS M A,BLAUWENDRAAT C,VALLERGA C L,et al.Identification of novel risk loci,causal insights,and heritable risk for Parkinson′s disease:a meta-analysis of genome-wide association studies［J］.Lancet Neurol,2019,18(12):1091-1102.
［42］ PANICKER N,SARKAR S,HARISCHANDRA D S,et al.Fynkinase regulates misfolded alpha-synuclein uptake and NLRP3 inflammasome activation in microglia［J］.Exp Med,2019,216(6):1411-1430.
［43］ FAN Y,MAGHIMAA M,CHINNATHAMBI A,et al.Tomentosin reduces behavior deficits and neuroinflammatory response in MPTP-induced Parkinson′s disease in mice［J］.J Environ Pathol Toxicol Oncol,2021,40(1):75-84.
［44］ ESTRADA-ORIHUELA S F,IBARRA-PREZ C.Lasalocid immediately and completely prevents the myocardial damage caused by coronary ischemia reperfusion in rat heart［J］.Mol Cell Biochem,2019,453(1/2)121-130.
［45］ YANG J,LV D J,LI L X,et al.Nicotine improved the olfactory impairment in MPTP-induced mouse model of parkinson′s disease［J］.Neuro Toxicology,2019,73:175-182.
相似文献/References:
[1]姜 山,石永兵,施晓松,等.哮喘患者外周血CD4 + 和CD25 + 调节性T细胞的变化及意义[J].新乡医学院学报,2006,23(05):531.
[2]马琪林,鲁丛霞,蔡琰,等.帕金森病患者血小板线粒体谷氨酸载体和复合物活性研究 [J].新乡医学院学报,2007,24(02):114.
[3]洪丽,李珂,闫晓海,等.瞬目反射与肛门括约肌肌电图对帕金森病患者病情分期判定的意义[J].新乡医学院学报,2012,29(12):936.
[4]朱丰霞,常海敏,段 瑛,等.人参皂苷 Rg1对帕金森病小鼠黑质中酪氨酸羟化酶及ephrinB2和磷酸化 c-Jun表达的影响[J].新乡医学院学报,2014,31(10):781.[doi:10.7683/xxyxyxb.2014.10.003]
[5]尹宝靓,潘 莹.人乳头瘤病毒感染与宫颈癌[J].新乡医学院学报,2014,31(12):1055.[doi:10.7683/xxyxyxb.2014.12.027]
[6]魏家彬,杨 帆,王淑秀.人参皂苷Ｒｇ１对１甲基４苯基１，２，３，６四氢吡啶诱导的帕金森病小鼠黑质酪氨酸蛋白激酶Ａ４表达的影响[J].新乡医学院学报,2015,32(05):404.
[7]李 乐,黄志勇,贺文麟.血浆同型半胱氨酸、催乳素水平与帕金森病及帕金森病痴呆相关性分析[J].新乡医学院学报,2015,32(05):438.
[8]曲 扬,舒永伟,张惊宇.重症肌无力的发病机制及治疗研究进展[J].新乡医学院学报,2018,35(7):637.[doi:10.7683/xxyxyxb.2018.07.023]
N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(4):637.[doi:10.7683/xxyxyxb.2018.07.023]
[9]牛草草,于鹏鑫,丁世彬,等.空气污染与糖尿病的关系研究进展[J].新乡医学院学报,2018,35(7):641.[doi:10.7683/xxyxyxb.2018.07.024]
N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(4):641.[doi:10.7683/xxyxyxb.2018.07.024]
[10]王东浩,黄艳梅,杨保胜.脊髓小脑性共济失调的基因诊断及治疗研究进展[J].新乡医学院学报,2016,33(7):639.[doi:10.7683/xxyxyxb.2016.07.025]
WANG Donghao,HUANG Yanmei,YANG Baosheng.Research progress of gene diagnosis and treatment of spinocerebellar ataxia[J].Journal of Xinxiang Medical University,2016,33(4):639.[doi:10.7683/xxyxyxb.2016.07.025]